Prestige Consumer Healthcare (PBH) Divestments (2016)
Prestige Consumer Healthcare (PBH) posted quarterly Divestments of $48.4 million for Q4 2016.
Prestige Consumer Healthcare (PBH) Divestments (2016) Analysis & Trends
Prestige Consumer Healthcare's Divestments history runs 1 years deep, the most recent figure standing at $48.4 million for Q4 2016.
- In Q4 2016, Divestments changed N/A year-over-year to $48.4 million; the TTM figure through Mar 2017 stood at $48.4 million (changed N/A YoY), while the FY2019 annual figure was $65.9 million, changed N/A from the prior year.
- Divestments for Q4 2016 stood at $48.4 million.
- The five-year high for Divestments was $48.4 million in Q4 2016, with the low at $48.4 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 65.64 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 48.40 Mn |